NAV
₹601.0510
as of 17 Jun 2026
Expense Ratio
—
see scheme documents
Viewing Direct · Growth
Lumpsum returns (CAGR)
- 1Y
- +6.47%
- 3Y
- +21.56%
- 5Y
- +13.81%
- Since Inception
- +17.36%
SIP returns (XIRR)
- 1Y
- +10.28%
- 3Y
- +13.14%
- 5Y
- +16.13%
- Since Inception
- +17.05%
Performance Comparison
Thinking about Nippon India Pharma Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Compare All Sectoral / Thematic FundsView all Sectoral / Thematic funds
Fund Details
Fund HouseNippon India Mutual Fund
CategorySectoral / Thematic
Launch Date01 Jan 2013
AMFI Code118759
Transaction facts
Min. Lumpsum₹5,000
Min. SIP₹100
Exit LoadW.E.F.March 17 2020 10% of the units allotted shall be redeemed without any exit load on or before completion of 12 months from the date of allotment of units. Any redemption in excess of such limit in the ? rst 12 months from the date of allotment shall be subject to the following exit load Redemption of units would be done on First in First out Basis (FIFO): ? 1% if redeemed or switched out on or before completion of 12 months from the date of allotment of units. ? Nil thereafter.
Available transactions
PurchaseSIPRedeemSWPSwitchSTPDemat
Portfolio holdings
as of 30 Apr 2026
portfolio shared with Nippon India Pharma Fund-Growth Plan-Growth Option
Holding% NAV
- 1Sun Pharmaceutical Industries Limited13.85%
- 2Lupin Limited7.95%
- 3Dr. Reddy'S Laboratories Limited7.04%
- 4Divi'S Laboratories Limited6.61%
- 5Cipla Limited5.47%
- 6Apollo Hospitals Enterprise Limited5.01%
- 7Medplus Health Services Limited3.78%
- 8Vijaya Diagnostic Centre Limited3.36%
- 9Sai Life Sciences Limited3.27%
- 10Ajanta Pharma Limited3.19%
Rows per page· 34 total
Page 1/4
Investment Objective
Nippon India Pharma Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Nippon India Pharma Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Nippon India Mutual Fund. The fund has been operational for over 13 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations